Table 2.

Changes in lipid levels (mean and SD) from the third month to each time point among patients with different endocrine therapies.

	TAM				OFS + TAM				OFS + AI
	3 months	6 months	12 months	24 months	3 months	6 months	12 months	24 months	3 months	6 months	12 months	24 months
	(baseline)				(baseline)				(baseline)
TC	4.60 ± 1.11	4.50 ± 1.00	4.53 ± 1.07	4.54 ± 1.01	4.55 ± 0.89	4.39 ± 0.80	4.45 ± 0.76	4.60 ± 0.86	4.88 ± 1.23	4.91 ± 0.88	5.10 ± 1.14	5.36 ± 1.15
(mmol/L)		P = 0.088	P = 0.194	P = 0.308		P = 0.171	P = 0.416	P = 0.560		P = 0.866	P = 0.226	P = 0.017
TG	1.88 ± 1.63	1.91 ± 1.34	1.89 ± 1.74	1.74 ± 1.54	2.10 ± 1.56	1.79 ± 0.74	1.88 ± 1.20	1.82 ± 0.76	1.32 ± 0.50	1.25 ± 0.57	1.29 ± 0.45	1.13 ± 0.35
(mmol/L)		P = 0.782	P = 0.971	P = 0.192		P = 0.091	P = 0.194	P = 0.105		P = 0.852	P = 0.927	P = 0.613
LDL-C	2.38 ± 0.92	2.25 ± 0.83	2.25 ± 0.88	2.19 ± 0.84	2.30 ± 0.71	2.22 ± 0.66	2.22 ± 0.62	2.23 ± 0.70	2.73 ± 0.89	2.88 ± 0.60	2.91 ± 0.81	3.01 ± 0.79
(mmol/L)		P = 0.004	P = 0.004	P < 0.001		P = 0.356	P = 0.342	P = 0.337		P = 0.319	P = 0.194	P = 0.067
HDL-C	1.38 ± 0.32	1.40 ± 0.34	1.43 ± 0.32	1.51 ± 0.34	1.42 ± 0.34	1.43 ± 0.31	1.47 ± 0.32	1.51 ± 0.30	1.35 ± 0.24	1.35 ± 0.29	1.41 ± 0.31	1.47 ± 0.24
(mmol/L)		P = 0.409	P = 0.018	P < 0.001		P = 0.767	P = 0.076	P = 0.015		P = 0.972	P = 0.360	P = 0.107

P value correspond to baseline (treated with endocrine therapy for 3 months).